EUVIMEDEUVIMED entdecken
Crossref

Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling

Mi Zhang, Ming Zhan iD, Xinyu Song

APMIS · 2025

DOI: 10.1111/apm.13507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Mi Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Yichang Central People's Hospital, Yichang, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Toll-Like Receptor 4, Mice, Inbred BALB C, NF-kappa B. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Gram‐negative bacterium Klebsiella pneumoniae ( K. pneumoniae ) is one major causative agent of community‐ and hospital‐acquired pneumonia. Echinacoside (ECH) is a phenylethanoid glycoside isolated from Cistanche deserticola that possesses anti‐inflammatory activity. Our research aimed to confirm whether ECH alleviates K. pneumoniae ‐induced pneumonia and explore the underlying regulatory mechanisms. BEAS‐2B cells and BALB/c mice were infected by K. pneumoniae to establish the cellular and animal models, respectively, followed by ECH treatment. Inflammatory cytokine levels were detected by RT‐qPCR and ELISA. The lung wet/dry (W/D) weight ratio and the myeloperoxidase (MPO) activity in lung tissues were examined. The pulmonary histopathologic changes were observed through hematoxylin and eosin (H&E) staining. The levels of TLR4/NF‐κB pathway‐associated molecules were estimated through western blotting, immunohistochemical, and immunohistochemical staining. K. pneumoniae infection caused lung histopathologic damage, enhanced MPO activity, elevated lung W/D weight ratio, and upregulated inflammatory cytokine levels in mice and promoted inflammatory cytokine expression in BEAS‐2B cells, which were reversed by ECH treatment. K. pneumoniae infection‐induced upregulation in TLR4, phosphorylated (p)‐p65, and p‐IκBα levels, and downregulation in IκBα levels in BEAS‐2B cells and pneumonia mice were overturned by ECH treatment. ECH ameliorates K. pneumoniae ‐induced pneumonia through suppressing the TLR4/NF‐κB pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeToll-Like Receptor 4Mice, Inbred BALB CNF-kappa BSignal TransductionKlebsiella InfectionsGlycosidesLungDisease Models, AnimalPneumonia, BacterialAnimalsHumansCytokinesMiceCell LineAnti-Inflammatory AgentsMaleCistanche

Stichwörter der Autor:innen

EchinacosideKlebsiella pneumoniaeTLR4/NF‐κB signaling pathwayinflammationpneumonia

Substanzen

Toll-Like Receptor 4NF-kappa BechinacosideGlycosidesCytokinesTlr4 protein, mouseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Respiratory, Yichang Central People's Hospital, Yichang, China.

ORCID-Profile: Ming Zhan

Zitieren

APA

Zhang, M., Zhan, M., & Song, X. (2025). Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling. APMIS. https://doi.org/10.1111/apm.13507

Vancouver

Zhang M, Zhan M, Song X. Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling. APMIS. 2025. doi:10.1111/apm.13507

BibTeX
@article{Zhang2025,
  author = {Zhang, Mi and Zhan, Ming and Song, Xinyu},
  title = {Echinacoside attenuates Klebsiella pneumoniae ‐induced pneumonia via inhibition of the TLR4 / NF ‐ κB signaling},
  journal = {APMIS},
  year = {2025},
  doi = {10.1111/apm.13507}
}
Kostenlos starten →